Cue Biopharma is trading 5.11% higher at $17.91 on October 21, 2026, likely reflecting broader biotechnology strength rather than a confirmed company catalyst.
- The supplied context reports the XBI rose 2.1% during the prior session; current search results also show gains in the biotech ETF.
- No new company-specific announcement explaining the move surfaced in available search results. The latest company filings and releases found predate October 21.